The pharmaceutical industry is in an exciting state of flux that is changing the industry in fundamental ways. While these changes are converging from several fronts, technological transformation has been identified as a priority that will significantly impact the industry in the near future. 

To better understand current views on technology software solutions that support clinical research and development (collectively referred to as “eClinical software solutions”), especially on a unified platform, Medidata surveyed current and former technology decision-makers representing large to mid-size pharmaceutical companies and contract research organizations (CROs).

Download this 15-page white paper for full insight. The key focus areas of the survey were as follows:

• Industry—Better understand what the industry views as the biggest need for eClinical platforms moving forward, given the increasing volume of data collected in clinical trials
• On-premise versus cloud—Determine the current state and expectations going forward for how and where Clinical software products will be hosted and the rationale for any changes in approach
• eClinical software architecture—Determine the current state and expectations going forward for eClinical software solutions architecture (e.g., stand-alone point solutions versus integrated applications versus integrated platforms versus unified platforms) and the rationale behind their approach
• Value proposition—Better understand the context for why, how, and when a unified platform solution could provide value in clinical trial planning and execution, which attributes are likely to drive adoption, and how success is measured for eClinical software solutions